Page 7 of 14

PE29.5 | Klinefelter Syndrome — SDL Guide

Learning Objectives

• Describe the genetic basis of Klinefelter syndrome including the 47,XXY karyotype, mechanism of non-disjunction, and mosaic/higher-grade variants
• Identify the characteristic clinical features of Klinefelter syndrome in childhood, at puberty, and in adulthood
• Explain the pathophysiology of primary hypogonadism, azoospermia, and gynaecomastia in Klinefelter syndrome
• Outline the investigation pathway including karyotype, gonadotropin profile, and fertility assessment
• Describe the management plan including testosterone replacement, gynaecomastia management, and fertility counselling via TESE and ICSI
• Counsel patients and families regarding recurrence risk and reproductive options

INSTRUCTIONS

Klinefelter syndrome (47,XXY) is the most common sex-chromosome aneuploidy in males and the most common cause of male hypogonadism and non-obstructive azoospermia. With a birth prevalence of approximately 1 in 500–600 live male births, it is encountered in paediatric, endocrine, and urology clinics. Despite this prevalence, the condition is significantly under-diagnosed — the majority of affected males are not diagnosed until adulthood when they present with infertility or androgen deficiency. Final-year students must understand the cytogenetic basis, recognise the clinical features at each life stage, interpret the hormonal profile, and counsel appropriately about testosterone replacement and fertility options.

References

• Ghai Essential Pediatrics, 9th ed., Ch. 22 — Chromosomal Disorders (textbook)
• Nelson Textbook of Pediatrics, 21st ed., Ch. 588 — Klinefelter Syndrome (textbook)
• Groth KA et al. — Klinefelter syndrome: a clinical update (2013), Journal of Clinical Endocrinology & Metabolism (guideline)
• Indian Academy of Pediatrics — Guidelines on Developmental Disorders (guideline)

---

Version 2.0 | NMC CBUC 2024

Clinical Presentation of Klinefelter Syndrome

Klinefelter syndrome is characterised by a remarkably variable phenotype — many affected males have mild or non-specific features, which explains the high rate of under-diagnosis. The classic full 47,XXY phenotype is most recognisable at puberty, when the contrast between tall stature with long limbs and small testes with incomplete virilisation becomes apparent. However, the condition has features across all life stages, and a paediatrician who knows what to look for can make the diagnosis in infancy or childhood rather than waiting for the pubertal presentation. The key insight is that the testes are normal-appearing in infancy and childhood, so the diagnosis in pre-pubertal boys relies on the softer clues of language delay, tall stature relative to the family, and learning difficulties. Only at puberty do the testes fail to enlarge appropriately, providing the cardinal physical finding that makes the diagnosis obvious if the examiner is looking for it.

Infancy and childhood (pre-pubertal):
• Language delay — the most consistent early finding; approximately 70–80% of boys with Klinefelter have delayed language development, reading difficulties, or learning disabilities. This is the most frequently missed early clue.
• Mild hypotonia and motor delay in infancy (less common than in Down syndrome).
• Tall stature relative to mid-parental height; long legs relative to trunk (eunuchoid proportions — arm span > height, lower segment > upper segment).
• Small testes may be noted on routine examination, though normal testicular size in childhood means this may not be apparent until puberty.

Puberty and adolescence (the classic presentation):
• Incomplete virilisation: Puberty begins at a normal age but fails to progress fully. Voice change is delayed or incomplete; beard and body hair remain sparse.
• Small, firm testes — the cardinal physical finding. Both testes are typically <4 mL bilaterally in post-pubertal males with Klinefelter (normal adult volume: 15–25 mL). The firmness reflects fibrosis and hyalinisation of the seminiferous tubules.
• Gynaecomastia — bilateral, usually non-tender breast tissue enlargement, present in approximately 50–75% of post-pubertal males. Results from an increased oestradiol-to-testosterone ratio due to peripheral aromatisation of androgens to oestrogens.
• Tall stature: final height typically 5–10 cm above mid-parental height centile.

Adulthood:
• Infertility — the most common presenting complaint in undiagnosed adults; azoospermia is nearly universal in 47,XXY males due to seminiferous tubule failure.
• Androgen deficiency symptoms: Reduced libido, erectile dysfunction, fatigue, decreased muscle mass, osteoporosis.
• Metabolic syndrome, type 2 diabetes, and cardiovascular risk are increased.

Klinefelter Syndrome: Clinical Features and Genetic Basis

Genetic Basis and Pathophysiology

Klinefelter syndrome results from the presence of an extra X chromosome in a phenotypic male, giving the karyotype 47,XXY. The extra X is maternally derived in approximately 50% of cases and paternally derived in approximately 50% — unlike trisomy 21, where the extra chromosome is predominantly of maternal origin. The mechanism is meiotic non-disjunction during either maternal or paternal gametogenesis. Unlike Down syndrome, the risk of Klinefelter syndrome does not increase significantly with maternal age, though a slight maternal age effect exists for the maternally-derived cases. The extra X chromosome is variably inactivated in different tissues, which contributes to the phenotypic variability.

Cytogenetic variants:

1. Classic 47,XXY (~80% of Klinefelter syndrome)
The karyotype shows 47 chromosomes with two X chromosomes and one Y. This is the most common variant and produces the full clinical spectrum described above. The extra X chromosome is largely inactivated (X-inactivation/Lyon hypothesis), but genes in the pseudoautosomal regions and other X-escaping genes have double dosage, contributing to the phenotype.

2. Mosaicism 46,XY/47,XXY (~10–20% of cases)
Post-zygotic non-disjunction produces two cell lines. The 46,XY cell line may partially rescue testicular function — mosaic Klinefelter may have less severe features, larger testes, and occasionally some residual spermatogenesis.

3. Higher-grade aneuploidies (rare): 48,XXXY; 49,XXXXY
With each additional X chromosome, the phenotype is more severe: greater intellectual disability, more pronounced skeletal abnormalities, and more complete gonadal failure.

Pathophysiology of key features:
• Testicular failure and azoospermia: The extra X chromosome disrupts seminiferous tubule development during fetal life. By puberty, hyalinisation and fibrosis of the seminiferous tubules are nearly complete in classic 47,XXY, resulting in non-obstructive azoospermia. Leydig cells (which produce testosterone) are less severely affected but still fail to maintain normal testosterone levels by late puberty.
• Testosterone deficiency → incomplete virilisation: The combination of Leydig cell dysfunction and reduced Sertoli cell inhibin B output results in low testosterone and markedly elevated FSH and LH (hypergonadotropic hypogonadism).
• Gynaecomastia: The relative testosterone deficiency leads to a shift in the oestradiol-to-testosterone ratio. Peripheral aromatisation (by adipose tissue) converts androgens to oestrogens; with less testosterone substrate, the relative excess of oestrogen stimulates breast glandular tissue.
• Tall stature: The extra X chromosome contains genes (possibly PAR1 SHOX) that promote long-bone growth; combined with delayed epiphyseal closure from androgen deficiency, final height is increased.

Pathophysiology of Klinefelter Syndrome

Diagnosis and Investigation

The diagnosis of Klinefelter syndrome is confirmed by karyotype. The clinical presentation — delayed or incomplete puberty, small firm testes, gynaecomastia, tall stature, or azoospermia in an adult — should trigger karyotype analysis. A hormonal profile provides supporting biochemical evidence and guides the urgency and specifics of management. Prenatal diagnosis is increasingly made by cfDNA screening. The investigation panel serves to confirm diagnosis, characterise the extent of gonadal failure, assess complications, and plan treatment. The hormonal pattern of elevated FSH and LH with low testosterone is the biochemical hallmark of primary gonadal failure in Klinefelter; it localises the defect to the gonads rather than the pituitary or hypothalamus and guides the choice of treatment (testosterone replacement, not gonadotropin stimulation). Understanding which investigation leads the diagnostic process and what each result means is essential for both the examination and for clinical practice.

Karyotype:
• Peripheral blood karyotype is confirmatory. For suspected mosaicism, a larger cell count (≥50 cells) should be analysed to avoid missing low-level mosaics.
• Identifies the specific variant: classic 47,XXY, mosaic 46,XY/47,XXY, or higher-grade aneuploidy.
• Prenatal diagnosis: cfDNA (NIPT) from ~10 weeks detects sex-chromosome aneuploidies; confirmation by amniocentesis provides definitive karyotype.

Hormonal profile:
• FSH: Markedly elevated (often >30–40 IU/L) — the most sensitive hormonal marker of seminiferous tubule failure; rises before testosterone falls.
• LH: Elevated due to Leydig cell failure.
• Testosterone: Low-normal in childhood; falls progressively through puberty; typically below the normal adult male range in untreated post-pubertal patients.
• Inhibin B: Very low or undetectable — produced by Sertoli cells; its absence reflects seminiferous tubule destruction.
• Oestradiol: Normal or mildly elevated (from peripheral aromatisation), contributing to gynaecomastia.

Semen analysis:
• In adolescents and adults: azoospermia (no sperm) is the rule in classic 47,XXY. Mosaic variants may have oligospermia.

Other investigations:
• Testicular ultrasound: Bilateral small testes with heterogeneous echotexture; calcifications may be present (reflecting tubular hyalinisation).
• Bone densitometry (DEXA): Osteoporosis risk from androgen deficiency.
• Thyroid function, fasting glucose, lipid profile: Metabolic surveillance.
• Neuropsychological assessment: Language, reading, and social cognition evaluation in children.

Hormonal Profile in Klinefelter Syndrome